• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.61% Nasdaq Up 0.24%

    Cascadian Therapeutics, Inc. (CASC)

    -NasdaqGS
    1.67 Up 0.02(1.21%) Sep 28, 4:00PM EDT
    Prev Close:1.65
    Open:1.66
    Bid:1.52 x 2000
    Ask:1.82 x 2500
    1y Target Est:65.00
    Beta:2.55362
    Earnings Date:Nov 3 - Nov 7 (Est.)
    Day's Range:1.59 - 1.74
    52wk Range:0.82 - 3.75
    Volume:1,253,759
    Avg Vol (3m):656,020
    Market Cap:225.97M
    P/E (ttm):N/A
    EPS (ttm):-0.55
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CASC

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:08-May-95

    Analysts

    Annual EPS Est (Jan-14) :N/A
    Quarterly EPS Est (Apr-13) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cascadian Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback